Literature DB >> 10074140

Gibbon ape leukemia virus receptor functions of type III phosphate transporters from CHOK1 cells are disrupted by two distinct mechanisms.

G J Chaudry1, K B Farrell, Y T Ting, C Schmitz, S Y Lie, C J Petropoulos, M V Eiden.   

Abstract

The Chinese hamster cell lines E36 and CHOK1 dramatically differ in susceptibility to amphotropic murine leukemia virus (A-MuLV) and gibbon ape leukemia virus (GALV); E36 cells are highly susceptible to both viruses, CHOK1 cells are not. We have previously shown that GALV can infect E36 cells by using both its own receptor, HaPit1, and the A-MuLV receptor, HaPit2. Given that the two cell lines are from the same species, the loss of function of both of these receptors in CHOK1 cells is surprising. Other studies have shown that CHOK1 cells secrete proteins that block A-MuLV entry into CHOK1 as well as E36, suggesting the two A-MuLV receptors are functionally identical. However, CHOK1 conditioned medium does not block GALV entry into E36, indicating the secreted inhibitors do not block HaPit1. HaPit1 and ChoPit1 therefore differ as receptors for GALV; ChoPit1 is either inactivated by secreted factors or intrinsically nonfunctional. To determine why GALV cannot infect CHOK1, we cloned and sequenced ChoPit1 and ChoPit2. ChoPit2 is almost identical to HaPit2, which explains why CHOK1 conditioned medium blocks A-MuLV entry via both receptors. Although ChoPit1 and HaPit1 are 91% identical, a notable difference is at position 550 in the fourth extracellular region, shown by several studies to be crucial for GALV infection. Pit1 and HaPit1 have aspartate at 550, whereas ChoPit1 has threonine at this position. We assessed the significance of this difference for GALV infection by replacing the aspartate 550 in Pit1 with threonine. This single substitution rendered Pit1 nonfunctional for GALV and suggests that threonine at 550 inactivates ChoPit1 as a GALV receptor. Whether native ChoPit1 functions for GALV was determined by interference assays using Lec8, a glycosylation-deficient derivative of CHOK1 that is susceptible to both viruses and that has the same receptors as CHOK1. Unlike with E36, GALV and A-MuLV exhibited reciprocal interference when infecting Lec8, suggesting that they use the same receptor. We conclude both viruses can use ChoPit2 in the absence of the inhibitors secreted by CHOK1 and ChoPit1 is nonfunctional.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074140      PMCID: PMC104050     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus.

Authors:  D G Miller; R H Edwards; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

2.  Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses.

Authors:  C A Wilson; M V Eiden
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 Chinese hamster cells.

Authors:  M A Eglitis; M V Eiden; C A Wilson
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  Factors affecting retroviral vector function and structural integrity.

Authors:  J R McLachlin; N Mittereder; M B Daucher; M Kadan; M A Eglitis
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

5.  Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus.

Authors:  S V Johann; J J Gibbons; B O'Hara
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.

Authors:  A D Miller; J V Garcia; N von Suhr; C M Lynch; C Wilson; M V Eiden
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Definition of a domain of GLVR1 which is necessary for infection by gibbon ape leukemia virus and which is highly polymorphic between species.

Authors:  S V Johann; M van Zeijl; J Cekleniak; B O'Hara
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections.

Authors:  C S Tailor; Y Takeuchi; B O'Hara; S V Johann; R A Weiss; M K Collins
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus.

Authors:  Y Takeuchi; R G Vile; G Simpson; B O'Hara; M K Collins; R A Weiss
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more
  15 in total

1.  Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor.

Authors:  C Salaün; P Rodrigues; J M Heard
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference.

Authors:  Z Jobbagy; S Garfield; L Baptiste; M V Eiden; W B Anderson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Characterization of hortulanus endogenous murine leukemia virus, an endogenous provirus that encodes an infectious murine leukemia virus of a novel subgroup.

Authors:  Christopher H Tipper; Craig E Bencsics; John M Coffin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

6.  Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms.

Authors:  C S Tailor; A Nouri; D Kabat
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.

Authors:  Adam S Lauring; Heather H Cheng; Maribeth V Eiden; Julie Overbaugh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Reassessing the role of region A in Pit1-mediated viral entry.

Authors:  Karen B Farrell; Jill L Russ; Ravi K Murthy; Maribeth V Eiden
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus.

Authors:  Anna L Barnett; David L Wensel; Weihua Li; Deborah Fass; James M Cunningham
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.